Advances in treating HER2-positive breast cancer: An interview with Sunil Verma

2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This artice is free to access.

Abstract

In this podcast, we talk to Dr Sunil Verma about the evolution of HER2 as a therapeutic target in breast cancer, and about how targeted therapy has revolutionized breast cancer treatment. We also discuss new agents in clinical development and the ways in which advances in treating HER2-positive breast cancer can be used to inform treatment decisions in other areas of medicine. The podcast for this interview is available at: http://media.biomedcentral.com/content/movies/supplementary/SunilVerma-QandA.mp3.

Author supplied keywords

Cite

CITATION STYLE

APA

Verma, S. (2014). Advances in treating HER2-positive breast cancer: An interview with Sunil Verma. BMC Medicine, 12(1). https://doi.org/10.1186/s12916-014-0129-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free